Certain former shareholders misrepresented critical information
Misrepresented critical info about US DoJ and FDA probes
Continue to support in efforts to correct the conduct of past
Efforts include significant changes to company’s management, operations.
Thursday, May 23, 2013
Epic Update : Ranbaxy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment